Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14080751 | 0.92 | NOTUM (0.52) | MAPTLMNANOTUMTP53SMN1; SMN2 | |
| SCHEMBL27838898 | 0.92 | NOTUM (0.52) | MAPTLMNANOTUMTP53SMN1; SMN2 | |
| SCHEMBL6493307 | 0.89 | NPC1 (0.40) | MAPTLMNATP53SMN1; SMN2NPC1 | |
| SCHEMBL9582303 | 0.89 | RPS6KA3 (0.43) | MAPTLMNATP53PKMSMN1; SMN2 | |
| SCHEMBL8187863 | 0.89 | NPC1 (0.40) | MAPTLMNATP53SMN1; SMN2NPC1 | |
| SCHEMBL7247277 | 0.89 | CYP3A4 (0.42) | MAPTLMNATP53SMN1; SMN2NPC1 | |
| SCHEMBL7050896 | 0.86 | LMNA (0.32) | MAPTLMNAMAPK14 | |
| SCHEMBL6766121 | 0.86 | LMNA (0.32) | MAPTLMNAMAPK14 | |
| SCHEMBL6763644 | 0.86 | LMNA (0.32) | MAPTLMNAMAPK14 | |
| SCHEMBL7258058 | 0.80 | P2RY6 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | claimed |
| EP-4288415-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | Wisconsin Alumni Research Foundation (US) | 2023-12-13 | — | — | EP | claimed |
| US-20230060532-A1 | METAL-ORGANIC FRAMEWORK COATED ORGANIC FIELD EFFECT TRANSISTOR BASED NO2 SENSOR AND METHOD | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2023-03-02 | — | — | US | claimed |
| US-20220363663-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2022-11-17 | — | — | US | claimed |
| WO-2022236241-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-11-10 | — | — | WO | claimed |
| US-20220340423-A1 | Photothermal Catalytic Method for Production of Hydrogen Peroxide without Sacrificial Reagents on Basis of Porphyrin-based Supermolecule | JIANGNAN UNIVERSITY (CN) | 2022-10-27 | — | — | US | claimed |
| WO-2021156733-A1 | METAL-ORGANIC FRAMEWORK COATED ORGANIC FIELD EFFECT TRANSISTOR BASED NO2 SENSOR AND CORRESPONDING FABRICATION METHOD | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2021-08-12 | — | — | WO | claimed |
| US-20170143633-A1 | NANOPARTICLES, METHOD OF PREPARING THE SAME AND THEIR USE | CITY UNIVERSITY OF HONG KONG (HK) | 2017-05-25 | — | — | US | claimed |
| US-9287568-B2 | High performance, high durability non-precious metal fuel cell catalysts | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-03-15 | — | — | US | claimed |
| US-20110319257-A1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-12-29 | — | — | US | claimed |
| US-4987226-A | CATALYSTS FOR EPOXIDATION OF OLEFINS WITH HYDROGEN PEROXIDE | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1991-01-22 | — | — | US | claimed |
| US-4973718-A | RHENIUM PROPHYRIN CATALYST | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1990-11-27 | — | — | US | claimed |
| EP-0308791-B1 | PROCESS FOR THE CATALYTIC EPOXYDATION OF OLEFINS WITH HYDROGEN PEROXIDE | Degussa Aktiengesellschaft (DE) | 1990-11-14 | — | — | EP | claimed |
| EP-0283753-B1 | PROCESS FOR THE CATALYTIC EPOXIDATION OF OLEFINS WITH HYDROGEN PEROXIDE | Degussa Aktiengesellschaft (DE) | 1990-09-19 | — | — | EP | claimed |
| US-4845252-A | COMPLEX TUNGSTEN CATALYST | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | claimed |
| EP-0308790-A2 | Rhenium-oxo-porphyrin complexes | Degussa Aktiengesellschaft (DE) | 1989-03-29 | — | — | EP | claimed |
| EP-0308791-A1 | Process for the catalytic epoxydation of olefins with hydrogen peroxide | Degussa Aktiengesellschaft (DE) | 1989-03-29 | — | — | EP | claimed |
| EP-0283753-A1 | Process for the catalytic epoxidation of olefins with hydrogen peroxide | Degussa Aktiengesellschaft (DE) | 1988-09-28 | — | — | EP | claimed |
| EP-0283754-A2 | Tungsten oxo-porphyrin complexes | Degussa Aktiengesellschaft (DE) | 1988-09-28 | — | — | EP | claimed |
| EP-0222167-A2 | Process for the catalytic epoxidation of olefines with hydrogen peroxide | Degussa Aktiengesellschaft (DE) | 1987-05-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363663-A1 | PYRIDINIUM DERIVATIVES MADE BY HYDROTHERMAL SYNTHESIS FOR USE AS ANOLYTES IN ELECTROCHEMICAL CELLS | PDXK, PNPO, ANO2 | MAPT 2168/4885LMNA 2300/4885NOTUM 1455/4885 |
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | TPO, PPOX, THPO | MAPT 2755/4885LMNA 3735/4885NOTUM 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.